Huntington’s disease and NMDA receptors; a new arena for therapeutic development
Huntington’s disease (HD) is an inheritable autosomal dominant neurodegenerative disorder characterized by a clinical triad of progressive choreiform movements (dance-like movements), psychiatric symptoms, and a decline in the cognitive functions. It is caused by a CAG trinucleotide repeat expansion...
Tallennettuna:
| Päätekijät: | , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Suez Canal University, Faculty of Pharmacy
2018-03-01
|
| Sarja: | Records of Pharmaceutical & Biomedical Sciences |
| Aiheet: | |
| Linkit: | https://rpbs.journals.ekb.eg/article_15368_9b06fc8550890d387b392351eec66fe1.pdf |
| Tagit: |
Ei tageja, Lisää ensimmäinen tagi!
|